Attenuated CyHV-1 and CyHV-2 Vaccine Candidates via ORF56-57 Deletion
The deletion of ORF56-57, as reported in this study for CyHV-3, presents a promising avenue for developing attenuated recombinant vaccine candidates against CyHV-1 and CyHV-2. This genetic modification could potentially reduce virulence while maintaining immunogenicity, paving the way for effective and safe vaccines against these viruses.
原文地址: https://www.cveoy.top/t/topic/fTFB 著作权归作者所有。请勿转载和采集!